The Hearing Implant Company

As the industry’s technology leader in implantable hearing solutions, MED−EL products are the result of 30 years of focused research and a commitment by its founders to fostering a company culture of excellence.

MED−EL has a strong tradition of advancing the technological and scientific foundation in the field of hearing implants. The company’s strong and consistent focus on research and development will continue to fuel the pipeline of new ideas and innovations. Our broad portfolio of products ensures that we can provide a hearing implant solution to fit each candidate’s unique hearing loss.

MED−EL was there at the beginning and they will be there for you today, tomorrow and in the future offering state−of−the−art hearing implant solutions that are comfortable to wear and easy to use.

Founders Dr. Ingeborg Hochmair and Prof. Erwin Hochmair at MED-EL international headquarters in Innsbruck.

World's Firsts

  • 1977
    Multi-channel micro-electronic CI
  • 1991
    BTE (Behind-the-Ear) processor
  • 1994
    Electrode array capable of stimulating entire length of cochlea
  • 1996
    Bilateral implantation for purpose of binaural hearing
  • 1996
    Miniaturised multichannel implant (4 mm thin)
  • 1999
    Modular BTE processor design making the body-worn processor obsolete
  • 2005
    EAS System integrating acoustic and electric stimulation
  • 2006
    Switch-free processor design featuring remote control
  • 2006
    FLEX Electrode array developed specifically for the most atraumatic insertion
  • 2006
    FineHearing™ technology providing the fine structure information of sound
  • 2007
    FLEXEAS indicated for partial deafness
  • 2008
    VIBRANT SOUNDBRIDGE Middle Ear Implant System with expanded indication for conductive and mixed hearing loss
  • 2009
    Middle Ear Implant System indicated for children
  • 2012
    BONEBRIDGE Active Bone Conduction Implant System
  • 2013
    Launch of the RONDO®, the first single-unit processor for cochlear implants.
  • 2013
    MED-EL receives CE mark approval for marketing cochlear implants for the indication of Single-Sided Deafness in children and adults as the first hearing implant company.
  • 2014
    Market relaunch for the new generation of the VIBRANT SOUNDBRIDGE implant and market launch of the new SAMBA* audio processor for the SOUNDBRIDGE and BONEBRIDGE.

ویژگیهای محصول، کاربرد و کارآیی مشمول تأیید مراجع ذیربط ملی است. برخی قابلیتها ممکن است در حال حاضر قابل استفاده نبوده یا MED-EL آنها را در منطقه شما عرضه نکرده باشد. برای کسب اطلاعات بیشتر با نمایندگی MED-EL در محل خود تماس بگیر

© 2017 MED-EL